LIXTE BIOTECHNOLOGY HLDGS IN's ticker is LIXT and the CUSIP is 539319202. A total of 16 filers reported holding LIXTE BIOTECHNOLOGY HLDGS IN in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $93,000 | -25.0% | 166,667 | 0.0% | 0.07% | -24.7% |
| Q2 2022 | $124,000 | -39.5% | 166,667 | 0.0% | 0.09% | -35.4% |
| Q1 2022 | $205,000 | +3.5% | 166,667 | 0.0% | 0.14% | +14.3% |
| Q4 2021 | $198,000 | -42.9% | 166,667 | 0.0% | 0.13% | -44.0% |
| Q3 2021 | $347,000 | -31.3% | 166,667 | 0.0% | 0.22% | -28.6% |
| Q2 2021 | $505,000 | -7.8% | 166,667 | 0.0% | 0.32% | -10.8% |
| Q1 2021 | $548,000 | +3.8% | 166,667 | 0.0% | 0.35% | -9.5% |
| Q4 2020 | $528,000 | – | 166,667 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SANTA MONICA PARTNERS LP | 166,667 | $548,000 | 0.35% |
| Almanack Investment Partners, LLC. | 1,042,105 | $3,429,000 | 0.35% |
| SABBY MANAGEMENT, LLC | 79,735 | $262,000 | 0.05% |
| WELLS FARGO & COMPANY/MN | 16 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,574 | $5,000 | 0.00% |
| MORGAN STANLEY | 21,053 | $69,000 | 0.00% |
| BlackRock Inc. | 303 | $1,000 | 0.00% |
| Citadel Advisors | 23,813 | $79,000 | 0.00% |